+Search query
-Structure paper
Title | Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma. |
---|---|
Journal, issue, pages | Eur. J. Med. Chem., Vol. 221, Page 113481-113481, Year 2021 |
Publish date | Mar 18, 2021 (structure data deposition date) |
Authors | Jiang, B. / Jiang, J. / Kaltheuner, I.H. / Iniguez, A.B. / Anand, K. / Ferguson, F.M. / Ficarro, S.B. / Seong, B.K.A. / Greifenberg, A.K. / Dust, S. ...Jiang, B. / Jiang, J. / Kaltheuner, I.H. / Iniguez, A.B. / Anand, K. / Ferguson, F.M. / Ficarro, S.B. / Seong, B.K.A. / Greifenberg, A.K. / Dust, S. / Kwiatkowski, N.P. / Marto, J.A. / Stegmaier, K. / Zhang, T. / Geyer, M. / Gray, N.S. |
External links | Eur. J. Med. Chem. / PubMed:33945934 |
Methods | X-ray diffraction |
Resolution | 2.36 - 3 Å |
Structure data | PDB-7nxj: PDB-7nxk: |
Chemicals | ChemComp-5I1: ChemComp-HOH: ChemComp-UUB: |
Source |
|
Keywords | TRANSCRIPTION / CDK13 / Cyclin K / CCNK / THZ531 / kinase / CDK12 / BSJ-01-175 |